Literature DB >> 1980292

The influence of density on the gastrointestinal transit of pellets.

J E Devereux1, J M Newton, M B Short.   

Abstract

The gastric emptying, intestinal transit and caecum arrival times of 1 mm pellets of density 1.5 and 2.8 g cm-3 have been assessed in fed and fasted volunteers by means of gamma-scintigraphy. The pellets were prepared by extrusion/spheronisation, coated with ethylcellulose and labelled with technetium-99m. The position of the pellets in the gastro-intestinal tract was followed by a double-headed gamma camera to allow detailed information over a period of up to 10 h. Analysis of variance established that there was a highly significant difference in the time for 50% of the pellets to empty from the stomach both in fed and fasted states. The 2.8 g cm-3 pellets had an extended resident time in both the fed and fasted states. The gastric emptying time was prolonged in the fed state. There was no significant difference in intestinal transit time between the two formulations nor whether the volunteers were fed or fasted. The caecum arrival time was therefore modified only by the gastric emptying time.

Entities:  

Mesh:

Year:  1990        PMID: 1980292     DOI: 10.1111/j.2042-7158.1990.tb06604.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  13 in total

1.  Simultaneous in vivo visualization and localization of solid oral dosage forms in the rat gastrointestinal tract by magnetic resonance imaging (MRI).

Authors:  V Christmann; J Rosenberg; J Seega; C M Lehr
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

Review 2.  Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Authors:  S S Davis; J G Hardy; S P Newman; I R Wilding
Journal:  Eur J Nucl Med       Date:  1992

3.  Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions.

Authors:  Emilie Hénin; Martin Bergstrand; Werner Weitschies; Mats O Karlsson
Journal:  Pharm Res       Date:  2015-11-09       Impact factor: 4.200

4.  Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors:  Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

5.  A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling.

Authors:  B Ploeger; T Mensinga; A Sips; J Meulenbelt; J DeJongh
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

Review 6.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 7.  Advances in colonic drug delivery.

Authors:  Abdul W Basit
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.

Authors:  Ahmad Y Abuhelwa; Stuart Mudge; David Hayes; Richard N Upton; David J R Foster
Journal:  Pharm Res       Date:  2016-04-27       Impact factor: 4.200

9.  Gastric emptying of pellets under fasting conditions: a mathematical model.

Authors:  Igor Locatelli; Ales Mrhar; Marija Bogataj
Journal:  Pharm Res       Date:  2009-04-01       Impact factor: 4.200

10.  Key formulation variables in tableting of coated pellets.

Authors:  V S N Murthy Dwibhashyam; J Vijaya Ratna
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.